|
|
||||||||||||||
|
|
|||||||||||||||
Therapeutics |
Clinical impact ratings GP/FP/Primary care






Public health 





Geriatrics 





Key Words: calcium carbonate dietary supplements fractures (bone)
| The first 150 words of the full text of this article appear below. |
METHODS
Design:
randomised, placebo controlled trial.
Allocation:
concealed.*
Blinding:
blinded {patients, healthcare providers, data collectors, and outcome assessors}
.*
Follow up period:
5 years.
Setting:
population-based study in Western Australia.
Participants:
1460 ambulatory women >70 years of age (mean age 75 y) who were not taking any medication affecting bone mass and were expected to survive >5 years.
Intervention:
calcium carbonate, 600 mg twice daily with meals (n = 730), or placebo (n = 730).
Outcomes:
incident atraumatic clinical fractures and symptomatic vertebral fractures (self reported and confirmed by radiographic reports), and adverse events requiring medical attention.
Patient follow up:
84% completed the study (100% included in the intention to treat analysis).
MAIN RESULTS
A total of 236 women sustained 297 new osteoporotic fractures. Calcium did not reduce the incidence of fractures overall or at any individual site (table
). In the 57% of women who were compliant (
80% of tablets taken)
Sophie A Jamal, MD
University of Toronto,
Toronto, Ontario, Canada
Relevant Article
Evid. Based Med. 2006 11: 159a.
(in Glossary)
This article has been cited by other articles:
![]() |
Correction Evid. Based Med., June 1, 2007; 12(3): 92 - 92. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |